Bocom Intl: rates the Mainland pharmaceutical industry as "leading", focusing on innovative and consumer-driven targets.
Chuangmei Pharmaceutical (02289.HK): Remain optimistic about the long-term outlook despite the setback in FY2017 results “Collection”
2289.HK: summary of the investigation of Foshan Logistics Center
02289.HK: long-term A-share issuance is conducive to thickening performance "collection"
02289.HK: business is on the rise to maintain "collection"
Chuangmei Pharmaceutical (02289.HK): the enterpriser of Guangdong pharmaceutical distribution market in China covers and gives the investment rating of "collection" for the first time.
2289.HK applies for purchase
New shares report of Chuangmei Pharmaceutical (2289.HK)
Unlock the Full List